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Abstract
Background: We studied the molecular basis of NSHL in Republic of Altai (South Siberia, Russia).
The Altaians are the indigenous Asian population of the Altai Mountain region considered as a
melting-pot and a dispersion center for world-wide human expansions in the past.
Methods: A total of 76 patients of Altaian, Russian or mixed ethnicity and 130 Altaian controls
were analyzed by PCR-DHPLC and sequencing in the GJB2 gene. The GJB6 deletion and the
common non-syndromic deafness-causing mitochondrial mutations were also tested when
appropriate.
Results: 8.3% of the Altaian chromosomes were carrying GJB2 mutations versus 46.9% of the
Russian chromosomes. The 235delC mutation was predominant among Altaians, whereas the
35delG mutation was most prevalent among Russian patients.
Conclusion:  We found an Asian-specific GJB2  diversity among Altaians, and different GJB2
contribution for deafness in the Altaian and Russian patients. The high carrier frequency of 235delC
in Altaians (4.6%) is probably defined by gene drift/founder effect in a particular group. The question
whether the Altai region could be one of founder sources for the 235delC mutation widespread in
Asia is open.
Background
Non-syndromic hearing loss (NSHL) accounts for approx-
imately 80% of cases of hereditary deafness and variety of
genes are involved in NSHL [1]. Mutations in the GJB2
gene, encoding the connexin 26 gap-junction protein,
account for a significant proportion of NSHL [2]. To date,
the substantial contribution of several nuclear genes [3,4]
and the pathogenic mitochondrial mutations in NSHL
was established in some populations [5,6]. Different pop-
ulation distributions of more than 70 GJB2  mutations
have been described and prevalence of some GJB2 muta-
tions is known to depend on population ethnic origin
[2,7]. The high frequencies of the 35delG mutation in the
Caucasians, the 167delT in Ashkenazi Jews, and the
235delC mutation among east Asian populations have
been shown to be the results of founder effects [8-12]. The
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underlying mechanisms accounting for the high preva-
lence of certain founder GJB2 alleles are unknown. The
data concerning the molecular basis of deafness in the
populations of Russia are scarce and mostly limited to the
European part of Russia and to the screening of the sole
mutation 35delG [13-16]. Such data are yet unknown for
Siberia (that is an expansive Asian part of Russia) popu-
lated by different ethnic groups.
The investigation presented here was performed on indi-
viduals with HI and subjects with normal hearing who are
living in the Republic of Altai, situated in South Siberia
and bordering Mongolia, China and Kazakhstan. Because
of location, the Altai have been a particular region of great
evolutionary importance. The archaeological, anthropo-
logical, and recent genetic data, mainly based on Y-chro-
mosome and mitochondrial DNA studies [17,18] suggest
that for thousand of years the Altai-Sayan Mountains with
surrounding territories have been a zone of the first con-
tacts between paleo-Caucasoids and Mongoloids; repeat-
edly this region was a peculiar "hybrid" area closely
connected with Central Asia, and a source of subsequent
human migrations.
Indigenous inhabitants of the Altai Republic are the Alta-
ians originated from several ancient Turkic-speaking
tribes [19]. The Altaians mainly belong to the Central
Asian type of the North Asian race. The Altai Republic
population accounts for about 200,000 including Alta-
ians, Russians, Kazakhs and other nationalities. The total
number of Altaians is about 60,000. The rural population
constitutes 3/4 of the Altai Republic people whereas
approximately 50,000 persons live in the city of Gorno-
Altaisk. The Altaians currently living in small settlements
in the distant regions of the Altai Republic have mainly
retained their native language, ethnic identity, and tradi-
tional marriage structure (patrilineal clan exogamy)
[20,21]. On the contrary, the population of the town
Gorno-Altaisk is characterized by higher rates of intereth-
nic marriages among Altaians, Russians and other ethnic-
ities. As a whole, the Altaian population was shown to be
genetic heterogeneous resulted from its territorial subdivi-
sion and the specific Altaian clan compositions in differ-
ent localities [20-22]. Recently, the first epidemiological
data in Altai Republic revealed the spectrum of hereditary
pathology in the Altai Republic population with different
prevalence rates among the urban and the rural popula-
tions, and among main ethnic groups of population (Rus-
sians, Altaians, Kazakhs) [23].
We report here the results of a study based on patients pre-
senting mainly prelingual deafness, with the mutation
analysis of the GJB2  gene, the screening of the GJB6-
D13S1830 deletion, and the study of five mitochondrial
mutations involved in NSHI. Moreover, the GJB2 screen-
ing was performed in 130 unrelated control subjects of
Altaian ethnicity.
Methods
Patients
This study was approved by the Altai Republic Ministry of
Health. Data on individuals with hearing impairment
were obtained from the Republican medical institutions,
Association of Deaf People, Specialized School for Deaf
Children of the Republic of Altai (the town Gorno-
Altaisk), and local settlements on the territory of the
Republic. We ascertained 76 patients with HI (37 males
and 39 females) of different ethnic affiliation (Altaians, n
= 40; Russians, n = 17; Kazakhs, n = 3; mixed or other eth-
nicity, n = 16) representing a total of 51 unrelated fami-
lies. Their ages ranged from 3 to 80 years old (mean 30.2).
Based on family histories, 19 patients were defined as spo-
radic cases, while 57 patients were issued from 32 unre-
lated families, presumably showing an autosomal
recessive (20 families), autosomal dominant or maternal
(8 families), and ambiguous (4 families) mode of inherit-
ance. In addition to the patients, 58 DNA samples of fam-
ily members with normal hearing were included.
Informed consent was obtained from all adult partici-
pants and from parents of the children studied.
Bilateral (mainly symmetrical) and prelingual/early onset
HL was defined in most of the patients. Among the 76
patients 44 could be otoscopically examined, and pure
tone audiometry was performed in the special medical
service (of the town Gorno-Altaisk). As the other patients
were mostly living in the small settlements distant from
the town Gorno-Altaisk, the data was collected from the
local unspecialized medical services and by direct inter-
view with the patients and their relatives. Among the clin-
ically documented patients (n = 44), HL was severe to
profound in 32 patients, moderate in 10, and mild in 2
patients. Sensorineural type of HI was precisely defined
for 38 out of 76 patients, and the remaining patients pre-
sented mixed (conductive-sensorineural, n = 6) or uncer-
tain type of HL. It should be noted that the chronic otitis
media, widespread in Altaian population, was frequently
registered in the medical histories of these patients. We
have analyzed the cohort of patients with HI without the
possibility of excluding cases of environmental exposures
(infections, prenatal or postnatal ototoxicity etc) or
unknown etiology.
Controls
130 unrelated subjects of Altaian origin with no familial
history of hearing problems were used as controls. Most of
DNA samples were obtained from the Southern Altaian
population of the Ust'-Kan administrative region of the
Altai Republic and the others from Northern AltaiansBMC Medical Genetics 2005, 6:12 http://www.biomedcentral.com/1471-2350/6/12
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living in the Turochak administrative region. All DNA
samples studied were anonymized.
Mutation analysis
DNA was extracted from peripheral blood using standard
protocols. GJB2 analysis was performed for the non-cod-
ing exon E1 and coding exon E2 and their flanking
sequences by PCR-DHPLC as previously described [24].
Any abnormal profile observed by DHPLC was conse-
quently analyzed by sequencing (ABI 310 sequencer,
Applied Biosystems). The patients without any mutations
in the coding exon E2 were analyzed in the non-coding
exon E1 and tested for the mutation ∆ (GJB6-D13S1830)
that includes the deletion of most of the GJB6 gene [24].
The screening of five known mitochondrial mutations
(m.A1555G, m.7445A>G, m.7472insC, m.7510T>C,
m.7511T>C) was performed in the GJB2 negative patients
that were compatible with a maternal inheritance of HI.
The A1555G mutation was analyzed as previously
described [5] whereas the four others were analyzed by
direct sequencing (position 7321–7620 of the mtDNA).
Statistical analysis
Differences between groups were analyzed by chi square
statistics. P-values were considered to be significant when
<0.05.
Results
GJB2 gene
GJB2 mutations were detected in 23.7% of the patients
(18 out of 76) (Table 1). We identified five different muta-
tions, all of them lying in the coding exon: three known as
recessive mutations (35delG, 235delC and 312del14),
one as a dominant mutation (R75Q), the fifth mutation is
a newly identified missense mutation, W172C. All the
patients with GJB2 mutations were familial cases present-
ing prelingual profound HL except one patient, genotyped
35delG/235delC, who had moderate-severe HL. Muta-
tions were present as homozygous or compound hetero-
zygous state, with the exception of the R75Q that was
identified as single in two members of family 11. Among
all the families studied, family 11 deserves particular
interest because dominant and pseudo-dominant deaf-
ness is observed with a complex segregation of different
mutations, as shown on Fig. 1 (see in Discussion).
Table 2 shows the distribution of GJB2 sequence varia-
tions in the two predominant ethnic groups (Altaians and
Russians) of patients as well as in Altaian controls. Of the
60 unrelated Altaian patient alleles, only 8.3% were carry-
ing GJB2 mutations with the 235delC representing 6.67%
of the alleles and the W172C, 1.67%. In contrast, 46.9%
(15 out of 32) of the unrelated Russian patient chromo-
somes carried GJB2 mutations with the 35delG account-
ing for the most frequent mutation (34.4%). The other
mutations 312del14, R75Q and 235delC were detected in
6.3%, 3.1% and 3.1% of the Russian alleles, respectively.
The polymorphism V27I and E114G were observed in
Altaian patients as well as in Altaian controls (Tables 1
and 2). None of the Russian patients had both variants.
Because the E114G variant was never identified as single
Pedigree of family 11 presented with the GJB2 genotypes Figure 1
Pedigree of family 11 presented with the GJB2 genotypes. Analyses were performed for the numbered subjects. ''+'' 
denotes that no GJB2 mutations were detected; ''nt'' – not tested. Ethnic affiliation of the parents: I-1 was Altaian; I-2, I-3, father 
of II-1 and father of III-1 were Russians; II-3 was of mixed ethnicity (Russian/Tatar).
I
II
III
nt
nt
nt
I-1
235delC/M34T
nt
nt
I-2 I-3
II-2 II-3 II-4 II-1
III-2 III-3
235delC/W172C R75Q/+
R75Q/+
+/+
R75Q/312del14
R75Q/235delC
R75Q/312del14
312del14/312del14 235delC/+
III-1BMC Medical Genetics 2005, 6:12 http://www.biomedcentral.com/1471-2350/6/12
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in our study but also in others [25,26] we assumed that
the E114G and V27I variants are in cis-configuration. The
estimated allele frequencies of V27I and [V27I; E114G]
are respectively 16.7% and 11.7% among 60 unrelated
Altaian patient chromosomes, versus 13.1% and 6.5% in
the Altaian controls (260 chromosomes). Furthermore,
three other known sequence variations were identified in
Altaian controls: the 235delC mutation (2.3%), the F191L
variation with unknown pathogenic consequences
(0.4%), and the non-pathogenic V153I variant (0.4%) as
shown on Table 2. A new sequence variation,
IVS1+27G>C, was identified in one Altaian patient with
severe-profound HL who had genotype IVS1+27G>C /
[V27I; E114G] (Table 1) and in his non-affected mother
(genotyped IVS1+27G>C/+). The IVS1+27G>C variation
was not previously described, but splice site prediction
programs would suggest its non-pathogenic consequences
[27]. Finally, the 765C>T polymorphism (referred to as
SNP1 [9]) located in the 3'UTR of the GJB2 gene was ana-
lyzed in patients. All alleles carrying the 35delG mutation
were associated with the 765T variant; that is in accord-
ance with recent data on the French patients [24].
∆ (GJB6-D13S1830) and mitochondrial mutations
Screening of the ∆ (GJB6-D13S1830) and mitochondrial
mutations m.1555A>G, m.7445A>G, m.7472insC,
m.7510T>C, m.7511T>C was negative in patients who
had no GJB2 mutations.
Discussion
Specific GJB2 mutation spectrums and different GJB2 con-
tributions for deafness were observed for the two main
ethnic groups studied here.
Prevalence of GJB2 mutations in Russian patients
GJB2 mutations are responsible for deafness in 54% (7
out of 13) of the independent Russian families tested and
the 35delG mutation was carried by 34.4% of the Russian
alleles. These findings correlate with earlier reported data
concerning Russian subjects with HI [13-16] and confirm
the main contribution of the 35delG mutation in deafness
among Caucasian populations [28,29].
GJB2 mutations with dominant and pseudo-dominant 
transmission
We studied the segregation of different GJB2 mutations in
a three-generation family (family 11; Fig. 1). All affected
members presented prelingual profound HL and were
using sign language to communicate. The dominant
mutation R75Q (224G>A) was found in five members, as
the sole mutation or in trans  of another mutation
(235delC or 312del14). R75Q was previously identified
as a non-syndromic dominant mutation [7] and as a syn-
dromic mutation [30] in a four-generation Turkish family
with autosomal dominant inherited HI and congenital
diffuse palmoplantar keratoderma. The age of onset and
progression of HL were variable among the affected mem-
bers of this family [30]. It should be noted that a previ-
ously described dominant mutation located at the same
codon 75 (R75W) was found to have a variable pene-
trance regarding skin disease symptoms (even to their
absence) [31,32]. Preliminary dermatological examina-
tion performed in all individuals of family 11 carrying the
R75Q mutation did not reveal any skin disease in patients
I-2, II-2 and II-4 though mild manifestation of probable
keratosis was detected in patients III-2 and III-3. However,
additional investigations need to be performed for eluci-
Table 1: GJB2 sequence variations identified in patients
Genotype Affected subjects (n = 76) Ethnic affiliation
Mutations
35delG / 35delG 7 (4 independent families) Russians
235delC / 235delC 1 Altaian
312del14 / 312del14 1 Russian/Tatar
35delG / 235delC 2 (unrelated) 1 – Russian/Altaian, 1 – Russian
35delG / 312del14 1 Russian
R75Qa / 235delC 1 Altaian/Russian
R75Q / 312del14 2 (two sibs) mixed ethnicity
R75Q/ + 2 (father and daughter) Russians
235delC / W172C 1 Altaian
Total 18 (23.7%)
Non-pathogenic variants
V27I / + 14 (11 independent families) 13 Altaians, 1 Kazakh
(V27I; E114G) b 7 (unrelated) 6 Altaians, 1 Altaian/Russian c
IVS1+27G>C / [V27I; E114G] 1 Altaian
Total 22 (28.9%)
a dominant mutation; b cis-configuration of V27I and E114G was confirmed by family studies in 5/7 patients, c the [V27I; E114G] allele of this proband 
is known to be of Altaian origin (maternal branch).BMC Medical Genetics 2005, 6:12 http://www.biomedcentral.com/1471-2350/6/12
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dation of non-syndromic and/or syndromic status of the
R75Q mutation as other factors can modulate the expres-
sion of a particular phenotype. The new missense muta-
tion W172C (516G>C) was identified in trans  of the
235delC allele in the Altaian patient I-1. This patient had
both parents and a brother with normal hearing but an
affected sister (not shown). A G>A substitution at position
516, generating a stop codon at position 172 (W172X)
had been previously described [7]; moreover, the tryp-
tophan at position 172 is conserved in many species
(human, mouse, rat, cow, sheep). These data tend to
imply that this GJB2 sequence variation is a severe reces-
sive mutation although de novo appearance of the W172C
mutation cannot be excluded in this case.
GJB2 contribution in Altaian patients and controls
This study has revealed an Asian-specific diversity and the
prevalence of GJB2 sequence variations in the Altaians.
High rates of the V27I and [V27I; E114G] alleles were
detected in Altaian patients and Altaian controls with no
significant differences between both groups (p > 0.05).
These results, once more, confirmed that both sequence
variations correspond to non-pathogenic polymorphisms
and (that their high rates) represent a distinctive feature of
particular Asian populations [10-12,25,33-36]. GJB2 gene
contribution in deafness among Altaians (8.3%) is mainly
defined by the recessive mutation 235delC (6.67%). This
mutation is specific to some east Asian populations
(Japan, China, Korea, Taiwan) with an allelic frequency
up to 20% among deaf patients and a carrier frequency of
0% to 2.8% in normal populations and it represents the
most prevalent GBJ2 pathogenic mutation as it accounts
Table 2: Frequency of the GJB2 sequence variations among patients and Altaian controls
Name Nucleotide change Number of unrelated chromosomes tested Frequency (95% CI)
Altaian patientsa n = 60 Altaian controls n = 260 Russian patientsb n = 32
235delC - 4
0.067
(0.019–0.144)
6
0.023
(0.009–0.045)
1
0.031
(0–0.118)
W172C 516G>C 1
0.017
(0–0.065)
0
0
(0–0.004)
0
0
(0–0.010)
35delG - 0
0
(0–0.017)
0
0
(0–0.004)
11
0.344
(0.192–0.515)
312del14 - 0
0
(0–0.017)
0
0
(0–0.004)
2
0.063
(0.007–0.172)
R75Q 224G>A 0
0
(0–0.017)
0
0
(0–0.004)
1
0.031
(0–0.118)
IVS1+27G>C 1
0.017*
(0–0.066)
-0
0**
(0–0.059)
V27I 79G>A 10
0.167
(0.085–0.271)
34
0.131
(0.093–0.175)
0
0
(0–0.010)
[V27I; E114G] 79G>A+341A>G 7
0.117
(0.049–0.210)
17
0.065
(0.039–0.099)
0
0
(0–0.010)
F191L 571T>C 0
0
(0–0.017)
1
0.004
(0–0.016)
0
0
(0–0.010)
V153I 457G >A 0
0
(0–0.017)
1
0.004
(0–0.016)
0
0
(0–0.010)
a the total number of unrelated Altaian chromosomes (n = 60) is the sum of twenty-six independent Altaian patients (52 chromosomes) and eight 
independent patients of mixed (Altaian/other) ethnicity (8 chromosomes); b the total number of unrelated Russian chromosomes (n = 32) is 
estimated from thirteen independent Russian patients (26 chromosomes) plus six chromosomes corresponding to six independent patients of 
mixed (Russian/other) ethnicity; * 58 chromosomes were tested for the GJB2 non-coding exon; ** 16 chromosomes were tested for the GJB2 non-
coding exon.BMC Medical Genetics 2005, 6:12 http://www.biomedcentral.com/1471-2350/6/12
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for up to 80% of the pathogenic alleles in patients [10-
12,33-37].
The 235delC mutation, found in 4/60 unrelated chromo-
somes in Altaian patients, was also detected in 6/130 Alta-
ian controls resulting in a carrier frequency of 4.6%,
higher than in any other Asian populations. This high fre-
quency could be attributed to the gene drift/founder
effects in a certain subpopulation. The Altaian control
group studied here consists mainly of the inhabitants of
one administrative region of the Altai Republic. Earlier, it
was shown that the marriage migrations among this Alta-
ian subpopulation were, in their majority, restricted to the
territory of this region [21].
Comparatively low GJB2 contribution among the Altaian
patients (8.3%) could be explained by the fact that a few
patients presented acquired hearing loss. Moreover, a spe-
cific marriage structure (patrilineal clan exogamy) prac-
ticed by the Altaians for a long time to avoid close
inbreeding, could influence apparent scarcity of affected
GJB2 homozygotes by restriction of random marriages of
Altaians belonged to certain clans. Finally, some other
deafness-causing genes, not considered in this study,
could be involved in deafness among Altaians. The addi-
tional study of the GJB2 gene diversity in other Altaian
groups will be informative for verification of the 235delC
prevalence pattern among the Altaians.
Recent studies had established that the 235delC mutation
among east Asian populations was derived from a com-
mon ancestral founder [10-12]. Yan et al. [12] roughly
estimated the age of the 235delC mutation to be about
11500 years old and speculated that the 235delC muta-
tion might have arisen in the Lake Baikal area and then
spread to Mongolia, China, and Japan through subse-
quent migrations. Taking into account that the territories
of South Siberia, including the Altai region and the Lake
Baikal area were melting-pots and dispersion centers for
world-wide human expansions in the past, we suggest that
the Altai region could be one of the founder sources for
the 235delC mutation widespread in Asia. To elucidate
this hypothesis, the 235delC prevalence will be tested
among indigenous people living in other regions of Altai
and surrounding territories and SNP analyses will be per-
formed to verify the common origin of the 235delC
alleles.
Conclusion
In this study we found an Asian-specific GJB2 diversity
among the Altaians and different GJB2 contribution for
deafness in the Altaian and Russian patients. Additional
investigations remain necessary to elucidate all genetic
origins of HL in Altaian patients. The high carrier fre-
quency of the 235delC mutation in normal hearing Alta-
ians (4.6%) is probably defined by gene drift/founder
effect in a particular Altaian group. The question whether
the Altai region could be one of the founder sources for
the 235delC mutation widespread in Asia is open. Finally,
we presented new evidence that the CX26 R75Q
mutation, earlier described as syndromic mutation (auto-
somal dominant inherited hearing impairment with con-
genital diffuse palmoplantar keratoderma), could be
associated with a high variable expression of the skin
symptoms.
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